More Articles

Browse More

Product Specials

Nina Tandon to Keynote AAID’s 2014 Annual Implant Dentistry Educational Conference

Posted on August 6, 2014

(CHICAGO, IL – August 5, 2014) The American Academy of Implant Dentistry has always been known as creating the curve in implant dentistry. This year's Annual Implant Dentistry Educational Conference keynote speaker, Nina Tandon, PhD will intrigue, motivate, and challenge the current thinking of implant dentistry and more. In her thrilling and eye-opening keynote, she will explain the process of growing tissue and transplants, and the future of medical science. With the help of manufacturing and information technology, we are on the verge of being able to grow human tissue.

Dr. Tandon believes that the era of engineered tissues—for example, a replacement kidney grown in the lab—is just beginning.  In this presentation, she will show how we (and our bodies) have lived through most of history (“Body 1.0”), and then how we evolved into "cyborgs" with implants such as pacemakers and artificial teeth (“Body 2.0”). Now, “Body 3.0” is all about growing our OWN body parts.

For her doctoral   dissertation research, Tandon grew cardiac cells that beat like tiny hearts.Dr. Tandon’s research is on the cutting edge of science: where sci-fi meets reality. She works on growing artificial hearts and bones that can be put into the body, and studies the new frontier of biotech: homes, textiles, and videogames made of cells. Profiled in Wired and named one of Fast Company's Most Creative People in Business, she speaks on the future of healthcare and technology, and biology's new industrial revolution.

Tandon is CEO and co-founder of EpiBone, the world’s first company growing living human bones for skeletal reconstruction. She is the coauthor of Super Cells: Building with Biology, a book that explores the new frontier of biotech. She is a TED Senior Fellow.  

She has a Bachelor’s in Electrical Engineering from the Cooper Union, a Master’s in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Tandon spent her early career in telecom at Avaya Labs and transitioned into biomedical engineering via her Fulbright Scholarship in Italy, where she worked on an electronic nose used to “smell” lung cancer.